Beer, Ambros J <br/><br/>
PET of αvbeta3-integrin and αvbeta5-integrin expression with 18F-fluciclatide for assessment of response to targeted therapy: ready for prime time?  [electronic resource] 

 -  Journal of nuclear medicine : official publication, Society of Nuclear Medicine  Mar 2011 
 - 335-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1535-5667 
<br/><br/><label>Standard No.: </label>10.2967/jnumed.110.078568  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--therapeutic use<br/>Animals<br/>Cell Line, Tumor<br/>Glioblastoma--diagnostic imaging<br/>Humans<br/>Indoles--therapeutic use<br/>Integrin alphaVbeta3--metabolism<br/>Male<br/>Mice<br/>Mice, Nude<br/>Peptides--pharmacokinetics<br/>Polyethylene Glycols--pharmacokinetics<br/>Pyrroles--therapeutic use<br/>Radionuclide Imaging<br/>Radiopharmaceuticals--pharmacokinetics<br/>Receptors, Vitronectin--metabolism<br/>Reproducibility of Results<br/>Sensitivity and Specificity<br/>Sunitinib